SB 3275 Hawaii Senate · 2026 Regular Session

RELATING TO CANNABIS.

Summary

Beginning January 1, 2027, legalizes low-dose and low-potency cannabis for personal adult use by persons over the age of twenty-one, including cultivation of a certain quantity of plants at a private residence. Legalizes cannabis accessories. Requires the Office of Medical Cannabis Control and Regulation to adopt rules to effectuate the legalization of low-dose and low-potency cannabis. (SD1)

Bill status passed 3 of 5 stages cleared

Introduction

Jan 2026

Committee Review

Feb 2026

Senate Passage

Feb 2026

House Passage

Governor

Introduced Jan 30, 2026 Last action Feb 20, 2026

Maddy AI version diff · 1 comparison

What changed between versions

SB3275 → SB3275_SD1 · 5 edits

MODERATE

This bill version shifts the regulatory authority for low-dose cannabis from the Department of Commerce and Consumer Affairs to the Office of Medical Cannabis Control and Regulation. It also updates the bill title to reflect this new oversight body and clarifies that the Office, rather than the Department, will create the necessary rules for cultivation and enforcement.

Scope change

The bill's scope of regulatory oversight changed from a general consumer affairs department to a specialized medical cannabis control office.

ENFORCEMENT

Regulatory authority was transferred from the Department of Commerce and Consumer Affairs to the Office of Medical Cannabis Control and Regulation for all rule-making and oversight.

DEFINITION

The definition of 'Tetrahydrocannabinol' was slightly modified to improve clarity regarding its function as a psychoactive component.

REQUIREMENT

The definition of 'Cultivate' was updated to use a non-breaking hyphen in 'low-dose' for formatting consistency.

TECHNICAL

The bill title was changed from 'SB3275' to 'SB3275 SD1' and the sponsor name was updated to Amy Vickers.

The description of the bill was updated to explicitly state that the Office of Medical Cannabis Control and Regulation will adopt the required rules.

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Feb 20, 2026

Upper · Passed

Report adopted; Passed Second Reading, as amended (SD 1) and referred to WAM/JDC.

upper

Feb 20, 2026

Committee

Reported from CPN/HHS (Stand. Com. Rep. No. 2654) with recommendation of passage on Second Reading, as amended (SD 1) and referral to WAM/JDC.

upper

Feb 19, 2026

Upper · Passed

The committee(s) on CPN recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in CPN were as follows: 3 Aye(s): Senator(s) Keohokalole, Awa; Aye(s) with reservations: Senator(s) McKelvey ; 2 No(es): Senator(s) Fukunaga, Lamosao; and 0 Excused: none.

upper

Feb 18, 2026

Upper · Passed

The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 5 Aye(s): Senator(s) San Buenaventura, McKelvey, Kanuha, Keohokalole, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.

upper

Feb 13, 2026

Upper · Passed

The committee(s) on CPN/HHS has scheduled a public hearing on 02-17-26 9:45AM; Conference Room 229 & Videoconference.

upper

Feb 2, 2026

Committee

Referred to CPN/HHS, WAM/JDC.

upper

Jan 30, 2026

Introduced

Introduced.

upper

1 primary · 0 co-sponsors